Adapted Physical Activity Centre (in The) CITY for Elders Aged 70 and Over with At Least One Long Term Illness
NCT ID: NCT04644861
Last Updated: 2024-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
37 participants
INTERVENTIONAL
2020-12-14
2023-02-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
"Sport on Prescription" in Primary Care for Patients With Long-term Illnesses
NCT05437978
Study of an Physical Exercise Program on Older People of 75 Years Old and More, Hospitalized in Geriatric Short Stay
NCT04327115
Cognitive and Physical Stimulation and Promotion of Social Relations for the Benefit of Older People's Quality of Life
NCT05721508
Physical Activity Program Implementation in Hospitalized Positive COVID-19 Older Adults
NCT04647682
Implementation and Effectiveness of a Community-based Exercise on Prescription Program for Adults With Chronic Diseases
NCT04919889
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Eligible patients addressed by their general practitioner will perform 4 months adapted physical activity program in the CAPA-CITY center (MSPU La Providence).
The inclusion will be realized by the sports doctor of CAPA-CITY. At M2, sport doctor and adapted physical activity teacher will meet the patient to readapt the program taking in count his particularity and wishes.
At M4 M6 and M12, an independent global evaluation will be realized by training nurse and clinical research associate.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Elders aged 70
Program of adapted physical activity
Program of adapted physical activity
3 workouts of one hour every week during 4 months. Program will be conducted by adapted physical activity teachers and sports doctor.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Program of adapted physical activity
3 workouts of one hour every week during 4 months. Program will be conducted by adapted physical activity teachers and sports doctor.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Living at home in Toulouse
* With a general practitioner working in Toulouse and agreed to participate to the CAPA-CITY70 program research
Exclusion Criteria
* Elders dependent for daily activity (score \< 5.5 Autonomy scale of Katz)
* Elders with dementia according to DSM V criteria
* Elders participating in another research project
* Contraindication for physical activity
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emile ESCOURROU
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Toulouse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de TOULOUSE
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A01164-35
Identifier Type: OTHER
Identifier Source: secondary_id
RC31/19/0057
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.